Literature DB >> 9365802

Plasma luteinizing hormone levels in response to gonadotropin-releasing hormone agonist and clonidine in Trypanosoma congolense-infected female goats.

A G Ng'wena1, N B Patel, E O Wango.   

Abstract

Trypanosomiasis, a parasitic disease of humans and animals, occurs over a wide area of Africa and imposes a large socioeconomic burden on the people. In the present study, we investigated whether trypanosomiasis-induced reproductive disorders were due to pituitary or hypothalamic dysfunction by determining plasma luteinizing hormone (LH) response to gonadotropin-releasing hormone (GnRH) agonist or clonidine in Trypanosoma congolense-infected female goats. With GnRH agonist administration, the total amount of LH secreted over a 140-min sampling period on day 23 and day 60 postinfection was consistently higher (71 and 21%, respectively) in infected goats compared to controls. In contrast, clonidine administration to infected goats on day 28 and day 69 postinfection failed to significantly alter the LH pulse frequency or the mean LH pulse amplitude over a 80-min sampling period. The results, especially the lack of response to clonidine, indicate that trypanosomiasis impairs GnRH release from the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365802     DOI: 10.1016/s0361-9230(97)00305-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  2 in total

1.  Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts.

Authors:  Rory E Morty; Patrick Bulau; Roger Pellé; Sherwin Wilk; Koji Abe
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

Review 2.  Circumventricular Organs and Parasite Neurotropism: Neglected Gates to the Brain?

Authors:  Marina Bentivoglio; Krister Kristensson; Martin E Rottenberg
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.